Description: OncoCyte Corporation focuses on developing diagnostic tests for the detection of breast, bladder, and lung cancers. The company was incorporated in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime Inc.
Home Page: oncocyte.com
OCX Technical Analysis
15 Cushing
Irvine,
CA
92618
United States
Phone:
949 409 7600
Officers
| Name | Title |
|---|---|
| Dr. Douglas T. Ross M.D., Ph.D. | Chief Science Officer |
| Mr. Ronald A. Andrews Jr. | Consultant |
| Mr. Joshua Riggs | Interim Chief Exec. Officer |
| Ms. Gisela A. Paulsen | COO & Pres |
| Mr. Anish John | Chief Financial Officer |
| Mr. James Liu | Controller & Principal Accounting Officer |
| Dr. Ekkehard Schutz M.D., Ph.D. | Chief Technology Officer |
| Mr. William Annett | Advisor |
| Mr. Robert S. Seitz | Head of Immune Oncology |
| Dr. Michael D. West Ph.D. | Scientific Advisor, Co-CEO of Biotime,Inc. & Pres of Biotime,Inc. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6484 |
| Price-to-Sales TTM: | 6.1307 |
| IPO Date: | 2016-01-04 |
| Fiscal Year End: | December |
| Full Time Employees: | 110 |